Join our daily newsletter At The Bell to receive exclusive market insights
- VIP Gloves (VIP) receives Australian Therapeutic Goods Administration (TGA) approval for its nitrile gloves
- The TGA has registered VIP’s nitrile examination and treatment gloves as a class one medical device and has given approval to sell the gloves in Australia
- This news follows USA Food and Drug Administration and European Union CE Mark approvals
- VIP is up 7.50 per cent and is trading at 4.3 cents per share at 2:25 pm AEST
VIP Gloves (VIP) has received Australian Therapeutic Goods Administration (TGA) approval for its nitrile gloves.
Nitrile gloves are a synthetic rubber compound as opposed to latex.
The TGA has registered VIP’s nitrile examination and treatment gloves as a class one medical device and has given approval to sell the gloves in Australia.
This news follows USA Food and Drug Administration and European Union CE Mark approvals.
Chairman Joe Wong is pleased to have secured TGA approval.
“We have been advancing distribution agreements for the Australian
market in recent months and, with TGA accreditation now received, these
can be finalised enabling sales to commence in the coming months,” Dr Wong said.
“VIP Gloves continues to expand its international sales footprint to become
a global glove supplier, providing a platform to launch the company’s house
brands as capacity expands in the coming months when the additional two
production lines come online.”
VIP was up 7.50 per cent and was trading at 4.3 cents per share at 2:25 pm AEST.
